226 related articles for article (PubMed ID: 37778627)
1. Should Biologics Be Used Before Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease?
Laidlaw TM; White AA
J Allergy Clin Immunol Pract; 2024 Jan; 12(1):79-84. PubMed ID: 37778627
[TBL] [Abstract][Full Text] [Related]
2. Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease-How to Choose.
Laidlaw TM; Chu DK; Stevens WW; White AA
J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1462-1467. PubMed ID: 34999274
[TBL] [Abstract][Full Text] [Related]
3. Aspirin-exacerbated respiratory disease: Updates in the era of biologics.
Mullur J; Buchheit KM
Ann Allergy Asthma Immunol; 2023 Sep; 131(3):317-324. PubMed ID: 37225000
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of aspirin exacerbated respiratory disease patients treated with aspirin desensitization and biologics.
D'Souza GE; Nwagu U; Barton B; Unsal AA; Rabinowitz MR; Rosen MR; Nyquist GG; Cohn J; Most J; Toskala EM
Int Forum Allergy Rhinol; 2022 Mar; 12(3):306-309. PubMed ID: 34719120
[No Abstract] [Full Text] [Related]
5. Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)?
Klimek L; Dollner R; Pfaar O; Mullol J
Curr Allergy Asthma Rep; 2014 Jun; 14(6):441. PubMed ID: 24682773
[TBL] [Abstract][Full Text] [Related]
6. Aspirin-exacerbated respiratory disease and current treatment modalities.
Sakalar EG; Muluk NB; Kar M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
[TBL] [Abstract][Full Text] [Related]
7. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
O'Brien EK; Jerschow E; Divekar RD
Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
[TBL] [Abstract][Full Text] [Related]
8. Current complications and treatment of aspirin-exacerbated respiratory disease.
Cook KA; Stevenson DD
Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
[TBL] [Abstract][Full Text] [Related]
9. Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease: Efficacy, tolerability, and patient experience.
Mullur J; Steger CM; Gakpo D; Bensko JC; Maurer R; Laidlaw TM; Buchheit KM
Ann Allergy Asthma Immunol; 2022 May; 128(5):575-582. PubMed ID: 35131410
[TBL] [Abstract][Full Text] [Related]
10. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
[TBL] [Abstract][Full Text] [Related]
11. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD).
Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT
Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997
[TBL] [Abstract][Full Text] [Related]
12. [Biologic therapy in patients with severe NSAID-exacerbated respiratory disease and previous aspirin desensitization : Results of a multicentric study].
Staufenberg AR; Frankenberger HK; Förster-Ruhrmann U; Spahn FC; Klimek L; Fruth K; Stihl C; Matthias C; Gröger M; Hagemann J
HNO; 2024 Jul; 72(7):473-483. PubMed ID: 38466409
[TBL] [Abstract][Full Text] [Related]
13. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
Walters KM; Waldram JD; Woessner KM; White AA
Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
[TBL] [Abstract][Full Text] [Related]
14. Appraisal of the Real-World Effectiveness of Biologic Therapies in Aspirin-Exacerbated Respiratory Disease.
Wangberg H; Spierling Bagsic SR; Osuna L; White AA
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):478-484.e3. PubMed ID: 34597850
[TBL] [Abstract][Full Text] [Related]
15. [Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?].
Klimek F; Förster-Ruhrmann U; Hagemann J; Cuevas M; Gröger M; Klimek L
HNO; 2024 Jul; 72(7):484-493. PubMed ID: 38409556
[TBL] [Abstract][Full Text] [Related]
16. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G
Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
[TBL] [Abstract][Full Text] [Related]
17. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.
Stevens WW; Jerschow E; Baptist AP; Borish L; Bosso JV; Buchheit KM; Cahill KN; Campo P; Cho SH; Keswani A; Levy JM; Nanda A; Laidlaw TM; White AA
J Allergy Clin Immunol; 2021 Mar; 147(3):827-844. PubMed ID: 33307116
[TBL] [Abstract][Full Text] [Related]
18. Successful Long-Term Aspirin Desensitization in a Pilot With Aspirin-Exacerbated Respiratory Disease.
Pacheco CS; Brooks RM; White KM
Mil Med; 2023 Jul; 188(7-8):e2826-e2828. PubMed ID: 36383070
[TBL] [Abstract][Full Text] [Related]
19. The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis.
Williams AN; Woessner KM
Curr Allergy Asthma Rep; 2008 May; 8(3):245-52. PubMed ID: 18589844
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.
Rajan JP; Wineinger NE; Stevenson DD; White AA
J Allergy Clin Immunol; 2015 Mar; 135(3):676-81.e1. PubMed ID: 25282015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]